Date Name Title Filing Type Shares Traded Price Total Held
May 06, 2020
Director
Director Form 4 Open market or private sale of non-derivative or derivative security 1,600 $541.66 77,366
Jun 22, 2017
EVP Research and Development
EVP Research and Development Form 4 Open market or private sale of non-derivative or derivative security 100 $541.70 23,950
Apr 17, 2020
EVP General Counsel and Secret
EVP General Counsel and Secret Form 4 Open market or private sale of non-derivative or derivative security 95 $541.94 16,610
Apr 17, 2020
EVP Finance CFO
EVP Finance CFO Form 4 Open market or private sale of non-derivative or derivative security 33 $542.25 25,298
Jul 27, 2015
Ten Percent Owner
Ten Percent Owner Form 4 Open market or private purchase of non-derivative or derivative security 253 $542.28 22,869,783
Apr 17, 2020
EVP General Counsel and Secret
EVP General Counsel and Secret Form 4 Open market or private sale of non-derivative or derivative security 5 $542.31 16,605
Nov 17, 2020
EVP Research
EVP Research Form 4 Open market or private sale of non-derivative or derivative security 294 $542.37 49,611
Jun 21, 2021
Director, President and Chief Scientific
Director, President and Chief Scientific Form 4 Open market or private sale of non-derivative or derivative security 10,514 $542.43 4,384
May 06, 2020
Director
Director Form 4 Open market or private sale of non-derivative or derivative security 496 $542.66 76,870
Dec 02, 2015
Director, President Regeneron Laboratori
Director, President Regeneron Laboratori Form 4 Open market or private sale of non-derivative or derivative security 1,098 $542.72 542,250

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.